caVos Biotech
Israel
unknown
unknown
Stage
About
caVos Biotech uses comparative genomics and AI to discover mRNA-based therapeutic candidates by identifying evolutionarily conserved, cross-species protein variants associated with longevity and disease resistance. The company focuses on indications such as fibrosis, tissue regeneration and cancer and pairs computational discovery with experimental validation.
Explore caVos Biotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.